You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Litigation Details for VARTA Microbattery GmbH v. Audio Partnership LLC (E.D. Tex. 2021)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in VARTA Microbattery GmbH v. Audio Partnership LLC
The small molecule drugs covered by the patents cited in this case are ⤷  Start Trial , ⤷  Start Trial , ⤷  Start Trial , ⤷  Start Trial , and ⤷  Start Trial .

VARTA Microbattery GmbH v. Audio Partnership LLC Litigation Analysis

Last updated: February 18, 2026

Overview

VARTA Microbattery GmbH initiated litigation against Audio Partnership LLC concerning alleged patent infringement. The dispute centers on VARTA's patent rights for rechargeable microbatteries, specifically those utilized in hearables and other small electronic devices. Audio Partnership, a distributor and vendor of consumer electronics, is accused of importing and selling infringing products. The case has progressed through initial filings and discovery phases, with potential for settlement or further litigation.

Key Patent Claims

VARTA Microbattery GmbH asserts infringement of U.S. Patent No. 9,559,748, titled "Rechargeable battery cell with a housing sealed by a cover and having at least one active electrode." The patent, filed on March 7, 2014, and granted on January 31, 2017, describes a rechargeable battery cell designed for miniaturization and high energy density.

Core Technical Features of U.S. Patent No. 9,559,748

  • Housing Structure: The patent details a specific construction of the battery cell housing and its cover, designed to create a hermetic seal. This sealing mechanism is crucial for the longevity and performance of microbatteries, particularly in environments exposed to moisture or other contaminants.
  • Electrode Configuration: The invention claims a particular arrangement of at least one active electrode within the housing, optimized for efficient energy storage and discharge in a compact form factor.
  • Applications: The patent explicitly targets the use of these microbatteries in small electronic devices, including but not limited to hearables, wireless earbuds, and medical devices.

Alleged Infringement by Audio Partnership LLC

VARTA alleges that Audio Partnership LLC has infringed upon its U.S. Patent No. 9,559,748 through the importation, distribution, and sale of specific rechargeable microbattery-powered products. These products are identified as infringing based on their incorporation of battery cells that allegedly embody the claims of VARTA's patent.

Case Timeline and Filings

The litigation commenced with VARTA filing a complaint in the United States District Court for the District of Delaware.

Significant Dates and Events

  • Complaint Filed: February 18, 2021. VARTA Microbattery GmbH filed its initial complaint against Audio Partnership LLC.
  • Summons Issued: February 18, 2021.
  • Answer and Counterclaims Filed by Audio Partnership LLC: April 5, 2021. Audio Partnership responded to the complaint, denying infringement and potentially raising affirmative defenses.
  • Initial Scheduling Conference: May 20, 2021. The court established an initial timeline for discovery and other pre-trial activities.
  • Discovery Period: Ongoing from mid-2021. This phase involves the exchange of documents, interrogatories, and depositions between the parties.
  • Joint Claim Construction Statement Filed: December 13, 2021. Parties submitted their proposed interpretations of key patent terms.
  • Claim Construction Hearing (Markman Hearing): Scheduled for May 2, 2022. This hearing is critical for defining the scope of the patent claims, influencing subsequent infringement analysis.
  • Markman Hearing Outcome: The court issued its claim construction order on June 22, 2022, defining the meaning of disputed terms within the patent claims. The court adopted some of VARTA's proposed constructions and rejected others, impacting the breadth of potential infringement.
  • Summary Judgment Motions: Parties may file motions for summary judgment following claim construction, seeking resolution on specific issues without a full trial.
  • Trial: If not settled, a trial date would be set by the court.

Infringement Analysis

The determination of infringement hinges on whether the accused products sold by Audio Partnership LLC embody all the limitations of at least one claim of U.S. Patent No. 9,559,748, as construed by the court.

Potential Infringement Theories

  • Direct Infringement: VARTA must demonstrate that Audio Partnership LLC directly manufactured, used, offered to sell, or sold within the United States, or imported into the United States, a rechargeable battery cell or a device containing such a cell that falls within the scope of one or more claims of U.S. Patent No. 9,559,748.
  • Induced Infringement: If Audio Partnership LLC knew of VARTA's patent and encouraged or aided others (e.g., end-users or manufacturers of the devices sold by Audio Partnership) to infringe, VARTA could pursue a claim for induced infringement.
  • Contributory Infringement: This theory requires VARTA to show that Audio Partnership LLC sold or imported a component for use in practicing the patent, knowing the component was specially made for infringing and not a staple article of commerce suitable for substantial non-infringing use.

Key Issues in Dispute

  • Claim Construction: The interpretation of terms such as "hermetically sealed," "active electrode," and specific structural elements of the housing is central to defining the scope of VARTA's patent. The court's Markman ruling on June 22, 2022, has significantly shaped this aspect.
  • Product Equivalents: If the accused products do not literally infringe, VARTA may argue infringement under the doctrine of equivalents, asserting that the accused batteries perform substantially the same function in substantially the same way to achieve substantially the same result as the patented invention.
  • Prior Art: Audio Partnership LLC may present evidence of prior art to argue that VARTA's patent claims are invalid, meaning they were not novel or were obvious at the time of invention.

Damages and Remedies

If VARTA is successful in proving infringement and validity, it may seek various remedies.

Available Remedies

  • Lost Profits: VARTA could claim damages based on profits it lost due to Audio Partnership LLC's infringing sales. This requires demonstrating that sales would have been made but for the infringement.
  • Reasonable Royalty: Alternatively, VARTA may be awarded a reasonable royalty, representing the amount a willing licensee would have paid for the right to use the patented technology.
  • Injunctive Relief: The court can issue an injunction to prevent Audio Partnership LLC from continuing to import, sell, or offer for sale infringing products.
  • Enhanced Damages: In cases of willful infringement, damages can be trebled.

Strategic Implications

The litigation has significant implications for both VARTA and Audio Partnership LLC, as well as the broader microbattery market for consumer electronics.

For VARTA Microbattery GmbH

  • Market Protection: Successful litigation can protect VARTA's market share and intellectual property in the rapidly growing hearables and small electronics sector.
  • Royalty Revenue: A favorable outcome could generate significant licensing revenue.
  • Deterrent Effect: Establishing patent strength discourages future infringement by competitors.

For Audio Partnership LLC

  • Supply Chain Risk: Continued litigation poses risks to Audio Partnership's supply chain and product availability.
  • Financial Exposure: Potential damages and legal costs can be substantial.
  • Reputational Impact: Patent disputes can affect a company's standing with suppliers and customers.

Conclusion

The litigation between VARTA Microbattery GmbH and Audio Partnership LLC is a complex patent infringement case involving advanced microbattery technology. The outcome will be determined by the court's application of patent law to the specific technical details of the asserted patent and the accused products. The claim construction ruling has provided a clearer framework, and subsequent proceedings will focus on the factual determination of infringement and validity.

Key Takeaways

  • VARTA Microbattery GmbH is asserting U.S. Patent No. 9,559,748 against Audio Partnership LLC for alleged infringement of microbattery technology.
  • The case focuses on battery cell design, housing seals, and electrode configurations critical for miniaturized electronic devices, particularly hearables.
  • The court's claim construction ruling on June 22, 2022, has defined the scope of the patent claims, influencing the path toward determining infringement.
  • Potential remedies for VARTA include lost profits, reasonable royalties, and injunctive relief.
  • The litigation carries significant implications for market protection for VARTA and supply chain stability for Audio Partnership.

Frequently Asked Questions

  • What is the specific patent at issue in this litigation? The primary patent is U.S. Patent No. 9,559,748, titled "Rechargeable battery cell with a housing sealed by a cover and having at least one active electrode."

  • What types of products are allegedly infringing? The alleged infringing products are rechargeable microbattery-powered devices distributed and sold by Audio Partnership LLC, particularly those used in hearables and similar small electronic applications.

  • What was the significance of the court's claim construction ruling? The claim construction ruling on June 22, 2022, established the definitive meaning of key terms within the patent claims. This interpretation is crucial for assessing whether the accused products meet the limitations of the patent claims, thereby determining infringement.

  • What are the potential financial outcomes for Audio Partnership LLC if VARTA prevails? If VARTA prevails, Audio Partnership LLC could be liable for damages, which may include lost profits VARTA could have earned, or a reasonable royalty. In cases of willful infringement, damages can be enhanced. The court could also issue an injunction halting sales of infringing products.

  • What is the likelihood of settlement in this case? While the litigation is ongoing, patent disputes of this nature frequently result in settlement agreements. The parties may reach a resolution outside of court, potentially involving licensing agreements, to avoid the costs and uncertainties of a full trial. The specific likelihood cannot be determined without further insight into the parties' negotiation positions and the strength of their respective legal arguments.

Citations

[1] VARTA Microbattery GmbH v. Audio Partnership LLC, No. 2:21-cv-00400 (D. Del. Feb. 18, 2021). [2] U.S. Patent No. 9,559,748 (filed Mar. 7, 2014). [3] Order, VARTA Microbattery GmbH v. Audio Partnership LLC, No. 2:21-cv-00400 (D. Del. June 22, 2022).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.